Center for Genomic Medicine and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston (A.P.P., A.V.K.).
Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA (A.P.P., M.W., A.V.K.).
Circulation. 2021 Aug 10;144(6):410-422. doi: 10.1161/CIRCULATIONAHA.120.052430. Epub 2021 Jul 12.
Individuals of South Asian ancestry represent 23% of the global population, corresponding to 1.8 billion people, and have substantially higher risk of atherosclerotic cardiovascular disease compared with most other ethnicities. US practice guidelines now recognize South Asian ancestry as an important risk-enhancing factor. The magnitude of enhanced risk within the context of contemporary clinical care, the extent to which it is captured by existing risk estimators, and its potential mechanisms warrant additional study.
Within the UK Biobank prospective cohort study, 8124 middle-aged participants of South Asian ancestry and 449 349 participants of European ancestry who were free of atherosclerotic cardiovascular disease at the time of enrollment were examined. The relationship of ancestry to risk of incident atherosclerotic cardiovascular disease-defined as myocardial infarction, coronary revascularization, or ischemic stroke-was assessed with Cox proportional hazards regression, along with examination of a broad range of clinical, anthropometric, and lifestyle mediators.
The mean age at study enrollment was 57 years, and 202 405 (44%) were male. Over a median follow-up of 11 years, 554 of 8124 (6.8%) individuals of South Asian ancestry experienced an atherosclerotic cardiovascular disease event compared with 19 756 of 449 349 (4.4%) individuals of European ancestry, corresponding to an adjusted hazard ratio of 2.03 (95% CI, 1.86-2.22; <0.001). This higher relative risk was largely consistent across a range of age, sex, and clinical subgroups. Despite the >2-fold higher observed risk, the predicted 10-year risk of cardiovascular disease according to the American Heart Association/American College of Cardiology Pooled Cohort equations and QRISK3 equations was nearly identical for individuals of South Asian and European ancestry. Adjustment for a broad range of clinical, anthropometric, and lifestyle risk factors led to only modest attenuation of the observed hazard ratio to 1.45 (95% CI, 1.28-1.65, <0.001). Assessment of variance explained by 18 candidate risk factors suggested greater importance of hypertension, diabetes, and central adiposity in South Asian individuals.
Within a large prospective study, South Asian individuals had substantially higher risk of atherosclerotic cardiovascular disease compared with individuals of European ancestry, and this risk was not captured by the Pooled Cohort Equations.
南亚裔个体占全球人口的 23%,对应 18 亿人,与大多数其他族裔相比,他们患动脉粥样硬化性心血管疾病的风险显著更高。美国实践指南现在将南亚裔视为一个重要的增强风险因素。在当代临床护理背景下,这种增强风险的幅度有多大,现有风险评估方法对其的捕捉程度,以及其潜在机制都需要进一步研究。
在英国生物库前瞻性队列研究中,对 8124 名南亚裔中年参与者和 449349 名在入组时无动脉粥样硬化性心血管疾病的欧洲裔参与者进行了研究。采用 Cox 比例风险回归评估了血统与动脉粥样硬化性心血管疾病事件(定义为心肌梗死、冠状动脉血运重建或缺血性卒中等)的发生风险之间的关系,并检查了广泛的临床、人体测量和生活方式因素。
研究入组时的平均年龄为 57 岁,其中 202405 人(44%)为男性。在中位随访 11 年期间,8124 名南亚裔参与者中有 554 人发生了动脉粥样硬化性心血管疾病事件,而 449349 名欧洲裔参与者中有 19756 人发生了该事件,相应的调整后风险比为 2.03(95%CI,1.86-2.22;<0.001)。这种相对较高的风险在一系列年龄、性别和临床亚组中基本一致。尽管观察到的风险高出 2 倍以上,但根据美国心脏协会/美国心脏病学会 pooled Cohort 方程和 QRISK3 方程预测的南亚裔和欧洲裔个体的 10 年心血管疾病风险几乎相同。对广泛的临床、人体测量和生活方式危险因素进行调整后,观察到的风险比仅略有减弱,降至 1.45(95%CI,1.28-1.65,<0.001)。对 18 个候选风险因素的方差解释评估表明,高血压、糖尿病和中心性肥胖在南亚裔个体中更为重要。
在一项大型前瞻性研究中,南亚裔个体发生动脉粥样硬化性心血管疾病的风险明显高于欧洲裔个体,且 pooled Cohort 方程无法捕捉到这种风险。